Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ProtoKinetix Inc PKTX

Healthcare Biotechnology
ProtoKinetix, Incorporated is a research and development stage biotechnology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company’s anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCQB:PKTX)

Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication

Business Wire June 6, 2023

ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants

Business Wire July 20, 2022

ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only

Business Wire January 14, 2022

ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease

Business Wire November 23, 2021

ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions

Business Wire May 12, 2021

ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes

Business Wire April 22, 2021

ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®

Business Wire April 14, 2021

Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration

Business Wire April 7, 2021

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

Business Wire November 24, 2020
View More News ››

Opinion & Analysis (OTCQB:PKTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCQB:PKTX)

zero activity

Is this company hand cream or what?
lashing - May 4, 2022

ProtoKinetix help me retire early baby!

To the moon! Baby! http://investorshub.advfn.com/ProtoKinetix-Inc-PKTX-2457/
SlimCarlos - January 23, 2017

target price

On their website they post a $1.32 target price. Grosvenor Financial Partners LLC Initial Report 9/26/07. Here, I'll paste it for you...
lindbeck - October 15, 2007

Peter Hodson...

& this man, on BNN, says that cdn. biotech is performing poorly. He would not buy unless Phase 3 results came out. FDA approval...
lindbeck - October 15, 2007

RE: Update,

I know very little about the company; got in on a "tip". I did call them a few weeks ago to gauge the market and did not get a...
Symmetrix - October 12, 2007

Update,

Does anyone have anything to say, good or bad, about this company? I'm really dying to know why the huge drop in s/p.
lindbeck - October 11, 2007
View more Bullboard ››

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ...
View More »